PATENT CLAIM ANALYSIS

Application Number: 16149912
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-09
Patent Classification: ["514", "210200"]

Abstract:
The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM) and conditions associated with left and/or right ventricular systolic dysfunction or systolic reserve. The synthesis and characterization of the compounds is described, as well as methods for treating DCM and other forms of heart disease.

Claim (Index 60):
The method of  claim 59 , wherein the carbon atom bearing R 1  and R 2  has a stereochemical R-configuration.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 97.0
- Lexical Diversity: 1.25532
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15003662', '14883152', '14309381', '14309414', '15514046']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7812606450538825
- 35 USC 102 Novelty (BERT): 0.5317063802156629
- Combined Prediction Score: 0.7563052185700605
- Mean Citation Score: 287.553448
- Max Citation Score: 348.63446
- Similarity Product: 223.0393127195978

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test